HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling.

AbstractPURPOSE:
Unique uptake and retention mechanisms of positron emission tomography (PET) hypoxia tracers make in vivo comparison between them challenging. Differences in imaged uptake of two common hypoxia radiotracers, [(61)Cu]Cu-ATSM and [(18)F]FMISO, were characterized via computational modeling to address these challenges.
MATERIALS AND METHODS:
An electrochemical formalism describing bioreductive retention mechanisms of these tracers under steady-state conditions was adopted to relate time-averaged activity concentration to tissue partial oxygen tension (PO(2)), a common metric of hypoxia. Chemical equilibrium constants of product concentration to reactant concentration ratios were determined from free energy changes and reduction potentials of pertinent reactions reported in the literature. Resulting transformation functions between tracer uptake and PO(2) were compared against measured values in preclinical models. Additionally, calculated PO(2) distributions from imaged Cu-ATSM tracer activity concentrations of 12 head and neck squamous cell carcinoma (HNSCC) patients were validated against microelectrode PO(2) measurements in 69 HNSCC patients.
RESULTS:
Both Cu-ASTM- and FMISO-modeled PO(2) transformation functions were in agreement with preclinical measured values within single-deviation confidence intervals. High correlation (r(2)=0.94, P<.05) was achieved between modeled PO(2) distributions and measured distributions in the patient populations. On average, microelectrode hypoxia thresholds (2.5 and 5.0 mmHg) corresponded to higher Cu-ATSM uptake [2.5 and 2.0 standardized uptake value (SUV)] and lower FMISO uptake (2.0 and 1.4 SUV). Uncertainties in the models were dominated by variations in the estimated specific activity and intracellular acidity.
CONCLUSIONS:
Results indicated that the high dynamic range of Cu-ATSM uptake was representative of a narrow range of low oxygen tension whose values were dependent on microenvironment acidity, while FMISO uptake was representative of a wide range of PO(2) values that were independent of acidity. The models shed light on possible causes of these discrepancies, particularly as it pertains to image contrast, and may prove to be a useful methodology in quantifying relationships between other hypoxia tracers. Comprehensive and robust assessment of tumor hypoxia prior to as well as in response to therapy may be best provided by imaging of multiple hypoxia markers that provide complementary rather than interchangeable information.
AuthorsStephen R Bowen, Albert J van der Kogel, Marianne Nordsmark, Søren M Bentzen, Robert Jeraj
JournalNuclear medicine and biology (Nucl Med Biol) Vol. 38 Issue 6 Pg. 771-80 (Aug 2011) ISSN: 1872-9614 [Electronic] United States
PMID21843774 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • Coordination Complexes
  • Copper Radioisotopes
  • Organometallic Compounds
  • Radioactive Tracers
  • Thiosemicarbazones
  • copper (II) diacetyl-di(N(4)-methylthiosemicarbazone)
  • fluoromisonidazole
  • Misonidazole
  • Oxygen
Topics
  • Biological Transport
  • Cell Hypoxia
  • Coordination Complexes
  • Copper Radioisotopes
  • Electrochemistry
  • Head and Neck Neoplasms (diagnostic imaging, metabolism, pathology)
  • Humans
  • Misonidazole (analogs & derivatives, chemistry, metabolism)
  • Models, Biological
  • Organometallic Compounds (chemistry, metabolism)
  • Oxygen (metabolism)
  • Positron-Emission Tomography
  • Radioactive Tracers
  • Reproducibility of Results
  • Thiosemicarbazones (chemistry, metabolism)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: